United States Gene Transfer Technologies Market Set for Breakthrough Growth with Cutting-Edge Innovations & Expanding Applications 2025 | Top key players - Danaher Corporation, Merck KGaA, Qiagen.

Market Size and Growth:

The Global Gene Transfer Technologies Market size reached US$ 3.78 Billion in 2024 from US$ 3.47 Billion in 2023 and is expected to reach US$ 8.74 Billion by 2033, growing at a CAGR of 9.8% during the forecast period 2025-2033.

The Gene Transfer Technologies Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Gene Transfer Technologies market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/gene-transfer-technologies-market?sz

The Gene Transfer Technologies Market refers to the industry focused on methods and tools that introduce genetic material into cells for therapeutic, research, and biotechnological applications. These technologies enable gene therapy, genetic engineering, and regenerative medicine, supporting advancements in treating genetic disorders, developing novel drugs, and enhancing agricultural and industrial biotechnology innovations.

Recent Key Developments of United States (U.S):

Strategic Collaboration for Gene Delivery: On September 15, 2025, Made Scientific and Basilard BioTech announced a collaboration to accelerate the development and manufacturing of next-generation gene delivery technologies. This partnership aims to scale Basilard's non-viral Celletto platform, which uses nanoneedles for efficient and viable gene transfer.

Expanded Clinical Trial for Gene Therapy: In July 2025, Atsena Therapeutics received FDA agreement to expand its Phase 1/2 clinical trial for a gene therapy aimed at reversing or preventing blindness. This development signifies progress in bringing new treatments for inherited retinal diseases to a broader patient population.

Launch of New Digital PCR Platforms: Bio-Rad Laboratories, Inc. launched four new Droplet DigitalTM PCR (ddPCRTM) platforms in July 2025. This advancement combines technologies from Bio-Rad and Stilla Technologies, offering new tools for genotyping and gene expression analysis, which are crucial for gene transfer research and development.

Novel FDA Approval for Gene-Modified Cellular Sheets: The FDA approved ZEVASKYN, a gene-modified cellular sheet, for the treatment of wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB). This approval, announced in August 2025, marks a significant step as the first and only autologous cell-based gene therapy for this condition.

Genprex Presentation at ASCO: In May 2025 (mentioned as a recent trend), Genprex, a clinical-stage gene therapy company, was selected to present at the 2025 American Society of Clinical Oncology (ASCO). The presentation of their cancer and diabetes therapies highlights ongoing research and development in the field.

Key Players:

Thermo Fisher Scientific Inc.
Danaher Corporation
Merck KGaA
Qiagen
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
MaxCyte
Cytiva
This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=gene-transfer-technologies-market

Market Segmentation:

By Product Type: Reagents, Kits and Assays, Consumables, Instruments, Others.

By Mode: Viral Vectors, Non-Viral Vectors, and Physical Methods.

By Method: In Vivo, Ex Vivo, In Vitro.

By Application: Therapeutic Applications, Research Applications, Others.

By End-User: Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/gene-transfer-technologies-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Gene Transfer Technologies market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Gene Transfer Technologies Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Gene Transfer Technologies market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Gene Transfer Technologies Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Gene Transfer Technologies Market in 2025?
◆ What is the projected growth rate of the Gene Transfer Technologies Market through 2033?
◆ Who are the key players in the Gene Transfer Technologies Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.